Results 151 to 160 of about 50,334 (225)

Hypoxia-Induced Ferroptosis Resistance Drives Orbital Fibrosis in Thyroid Eye Disease. [PDF]

Invest Ophthalmol Vis Sci
Gong C, Liu S, Zhao J, Zhu J, Xing C, Li K, Xie C, Wu N, Chen R.   +8 more
europepmc   +1 more source

Quantification of enlargement of the levator palpebrae superioris muscle in thyroid eye disease. [PDF]

Int Ophthalmol
Hains L, Rana K, Almater A, Patel S, Selva D.   +4 more
europepmc   +1 more source

Smoking-induced HLA-DQA1 overexpression in T cells: a novel pathway in thyroid eye disease development. [PDF]

Front Immunol
Su Y, Cao J.
europepmc   +1 more source

The therapeutic revolution in thyroid eye disease: from orbital radiotherapy to teprotumumab and AI. [PDF]

Front Med (Lausanne)
Yuan X, Li H, Wang F.
europepmc   +1 more source

Teprotumumab N01 for thyroid eye disease in China: clinical outcomes and quantitative MRI correlations. [PDF]

Front Med (Lausanne)
Wang Q, Cheng J, Yang C, Song J, Chen Y, Shen Y, Qu L, Wei R.   +7 more
europepmc   +1 more source

Exploring the Potential Roles of Oxidative Stress-Related Genes in Thyroid Eye Disease and Graves' Disease. [PDF]

J Ophthalmol
Zhang W, Huang Q, Jinying Li.
europepmc   +1 more source

Photographic evaluation of clinical activity score in thyroid eye disease. [PDF]

PLoS One
Lee GM, Lee MJ, Kim N, Choung H, Lee H, Cho WK, Moon JH, Khwarg SI.   +7 more
europepmc   +1 more source

A Deep Learning Framework for Predicting Teprotumumab Treatment Response in Thyroid Eye Disease. [PDF]

Ophthalmol Sci
Langarica S, Lee NG, Alkhadrawi AM, Kim YT, Ha SK, Do S, Lin LY.   +6 more
europepmc   +1 more source

Resolution of Thyroid Eye Disease-Related Diplopia Following Intentional Myopic Targeting With Unilateral Cataract Surgery. [PDF]

Cureus
Alkhater N, Al-Mahmood A.
europepmc   +1 more source